AAAAAA
Results:
1-15
|
Results: 15
Authors:
Nath, R
Yue, N
Citation: R. Nath et N. Yue, Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125 - model LS-1 Brachyseed (TM), APPL RAD IS, 55(6), 2001, pp. 813-821
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
Authors:
Brada, M
Hoang-Xuan, K
Rampling, R
Dietrich, PY
Dirix, LY
Macdonald, D
Heimans, JJ
Zonnenberg, BA
Bravo-Marques, JM
Henriksson, R
Stupp, R
Yue, N
Bruner, J
Dugan, M
Rao, S
Zaknoen, S
Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266
Authors:
Yue, N
Hollink, E
Guerin, F
Stephan, DW
Citation: N. Yue et al., Zirconium phosphinimide complexes: Synthesis, structure, and deactivation pathways in ethylene polymerization catalysis, ORGANOMETAL, 20(21), 2001, pp. 4424-4433
Authors:
Huq, MS
Yue, N
Suntharalingam, N
Citation: Ms. Huq et al., Experimental determination of depth-scaling factors and central axis depthdose for clinical electron beams, INT J CANC, 96(4), 2001, pp. 232-237
Authors:
Chen, Z
Yue, N
Wang, X
Roberts, KB
Peschel, R
Nath, R
Citation: Z. Chen et al., Dosimetric effects of edema in permanent prostate seed implants: A rigorous solution, INT J RAD O, 47(5), 2000, pp. 1405-1419
Authors:
Hehrlein, C
Kovacs, A
Wolf, GK
Yue, N
Nath, R
Citation: C. Hehrlein et al., A novel balloon angioplasty catheter impregnated with beta-particle emitting radioisotopes for vascular brachytherapy to prevent restenosis - First in vivo results, EUR HEART J, 21(24), 2000, pp. 2056-2062
Authors:
Nath, S
Chen, Z
Yue, N
Trumpore, S
Peschel, R
Citation: S. Nath et al., Dosimetric effects of needle divergence in prostate seed implant using I-125 and Pd-103 radioactive seeds, MED PHYS, 27(5), 2000, pp. 1058-1066
Authors:
Nath, R
Yue, N
Shahnazi, K
Bongiorni, PJ
Citation: R. Nath et al., Measurement of dose-rate constant for Pd-103 seeds with air kerma strengthcalibration based upon a primary national standard, MED PHYS, 27(4), 2000, pp. 655-658
Authors:
Nath, R
Yue, N
Citation: R. Nath et N. Yue, Dose distribution along the transverse axis of a new I-125 source for interstitial brachytherapy, MED PHYS, 27(11), 2000, pp. 2536-2540
Authors:
Yung, WKA
Albright, RE
Olson, J
Fredericks, R
Fink, K
Prados, MD
Brada, M
Spence, A
Hohl, RJ
Shapiro, W
Glantz, M
Greenberg, H
Selker, RG
Vick, NA
Rampling, R
Friedman, H
Phillips, P
Bruner, J
Yue, N
Osoba, D
Zaknoen, S
Levin, VA
Citation: Wka. Yung et al., A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse, BR J CANC, 83(5), 2000, pp. 588-593
Authors:
Yung, WKA
Prados, MD
Yaya-Tur, R
Rosenfeld, SS
Brada, M
Friedman, HS
Albright, R
Olson, J
Chang, SM
O'Neill, AM
Friedman, AH
Bruner, J
Yue, N
Dugan, M
Zaknoen, S
Levin, VA
Citation: Wka. Yung et al., Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse, J CL ONCOL, 17(9), 1999, pp. 2762-2771
Authors:
Yue, N
Chen, Z
Peschel, R
Dicker, AP
Waterman, FM
Nath, R
Citation: N. Yue et al., Optimum timing for image-based dose evaluation of I-125 and (PD)-P-103 prostate seed implants, INT J RAD O, 45(4), 1999, pp. 1063-1072
Authors:
Yue, N
Dicker, AP
Corn, BW
Nath, R
Waterman, FM
Citation: N. Yue et al., A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of I-125 or Pd-103 seed implant of prostate, INT J RAD O, 43(2), 1999, pp. 447-454
Authors:
Yue, N
Dicker, AP
Nath, R
Waterman, FM
Citation: N. Yue et al., The impact of edema on planning I-125 and Pd-103 prostate implants, MED PHYS, 26(5), 1999, pp. 763-767
Authors:
Yue, N
Chen, Z
Bond, JE
Son, YH
Nath, R
Citation: N. Yue et al., Combined use of transverse and scout computed tomography scans to localizeradioactive seeds in an interstitial brachytherapy implant, MED PHYS, 26(4), 1999, pp. 502-505
Risultati:
1-15
|